Health Care Sector Equities Technical Data -- Research on Albany Molecular Research, Agilent Technologies, Thermo Fisher Scientific, and ICON
PR Newswire - Tue May 13, 8:15AM CDT
The U.S. markets on Monday, May 12, 2014 ended on a positive note as the Dow Jones Industrial Average finished at 16,695.47, up 0.68% and the NASDAQ Composite closed at 4,143.86, up 1.77%. The S&P 500 finished the session 0.97% higher at 1,896.65. During the trading session, eight out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 675.29, up 1.04%, with the index advancing 4.74% in the last one month. Investor-Edge has initiated coverage on the following equities: Albany Molecular Research Inc. (NASDAQ: AMRI), Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO) and ICON PLC (NASDAQ: ICLR). Free technical research on AMRI, A, TMO and ICLR can be downloaded upon signing up at:
AMRI CEO to Present at the UBS Global Healthcare Conference
PR Newswire Europe - Thu May 08, 4:54AM CDT
Albany Molecular Research Inc. announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the UBS Global Healthcare Conference on Wednesday, May 21, 2014 at 11:00 a.m. ET.
Insider Trading Alert - AMRI, STT And MLNX Traded By Insiders
at The Street - Tue May 06, 12:45PM CDT
Stocks with insider trader activity include AMRI, STT and MLNX
AMRI Announces First Quarter 2014 Results
PR Newswire Europe - Tue May 06, 7:02AM CDT
-- Contract Revenue Growth of 10% to $51.0 Million and Adjusted Diluted EPS of $0.16
AMRI to Announce First Quarter Results
PR Newswire Europe - Tue Apr 22, 7:01AM CDT
AMRI today announced it will issue first quarter financial results before the opening of the market on Tuesday, May 6, 2014. Following the release of its results, the company will host a conference call and simultaneous audio webcast at 10:00 a.m. ET.
NY-based co. closing Syracuse-area lab in July
AP - Thu Apr 17, 10:10AM CDT
CICERO, N.Y. (AP) — An Albany-based pharmaceutical company that's part of a $250 million economic development project in Buffalo is shutting down its Syracuse-area research center, eliminating 45 jobs.
AMRI Realigns Discovery and Development Services to Support Customer Demand
PR Newswire Europe - Wed Apr 16, 8:01AM CDT
AMRI today announced that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y. site to other sites within AMRI and will cease operations in Syracuse by the end of June 2014. The actions taken today are consistent with AMRI's ongoing efforts to consolidate its facility resources to more effectively utilize its discovery and development resource pool and to further reduce its facility cost structure.
Morning Briefing on Top Gainers -- Research on Science Applications Intl., Maxwell Technologies, Albany Molecular Research, and Demandware
PR Newswire - Thu Apr 10, 12:04PM CDT
The US markets saw a positive sentiment on Wednesday, April 09, 2014, with the NASDAQ Composite closing at 4,183.90, up 1.72%, the Dow Jones Industrial Average ending the session at 16,437.18, up 1.11%, and the S&P 500 edging 1.09% higher to finish the trading session at 1,872.18. The session saw a positive impact from Information Technology, Health Care and Materials sectors along with a drag from Utilities and Telecommunication Services sectors. A number of stocks saw large movements, including Science Applications International Corp. (NYSE: SAIC), Maxwell Technologies Inc. (NASDAQ: MXWL), Albany Molecular Research Inc. (NASDAQ: AMRI) and Demandware Inc. (NYSE: DWRE). Free technical research on SAIC, MXWL, AMRI and DWRE can be downloaded upon signing up at:
Financial Results Announcement, Stock Movement, Presentations, and Acquisition - Analyst Notes on Universal Health Services, Tenet, Cynosure, Albany Molecular Research, and Enanta
PR Newswire - Thu Apr 10, 9:49AM CDT
Today, Analysts Review released its analysts' notes regarding Universal Health Services, Inc. (NYSE: UHS), Tenet Healthcare Corp. (NYSE: THC), Cynosure, Inc. (NASDAQ: CYNO), Albany Molecular Research Inc. (NASDAQ: AMRI), and Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Albany Molecular Research (AMRI) Showing Signs Of A Dead Cat Bounce Today
at The Street - Wed Apr 09, 8:59AM CDT
Trade-Ideas LLC identified Albany Molecular Research (AMRI) as a "dead cat bounce" (down big yesterday but up big today) candidate
AMRI Completes Acquisition of Cedarburg Pharmaceuticals, Inc.
PR Newswire Europe - Fri Apr 04, 3:10PM CDT
AMRI today announced that it has completed the previously announced acquisition of Cedarburg Pharmaceuticals, Inc.
Albany Molecular Research Has Returned 52.0% Since SmarTrend Recommendation (AMRI)
Comtex SmarTrend(R) - Fri Apr 04, 9:37AM CDT
SmarTrend identified an Uptrend for Albany Molecular Research (NASDAQ:AMRI) on February 12th, 2014 at $11.62. In approximately 2 months, Albany Molecular Research has returned 51.98% as of today's recent price of $17.66.
Insider Trading Alert - AMRI, CHE And LXK Traded By Insiders
at The Street - Thu Apr 03, 10:45AM CDT
Stocks with insider trader activity include AMRI, CHE and LXK
Albany Molecular Research Shares Up 58.9% Since SmarTrend's Buy Recommendation (AMRI)
Comtex SmarTrend(R) - Fri Mar 28, 9:09AM CDT
SmarTrend identified an Uptrend for Albany Molecular Research (NASDAQ:AMRI) on February 12th, 2014 at $11.62. In approximately 1 month, Albany Molecular Research has returned 58.95% as of today's recent price of $18.47.